Monte Rosa Therapeutics Statistics
Total Valuation
GLUE has a market cap or net worth of $304.47 million. The enterprise value is -$24.96 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GLUE has 61.51 million shares outstanding. The number of shares has increased by 43.80% in one year.
| Current Share Class | 61.51M |
| Shares Outstanding | 61.51M |
| Shares Change (YoY) | +43.80% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 0.96% |
| Owned by Institutions (%) | 57.78% |
| Float | 30.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.84 |
| Forward PS | 9.38 |
| PB Ratio | 1.37 |
| P/TBV Ratio | 1.37 |
| P/FCF Ratio | 8.01 |
| P/OCF Ratio | 7.25 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.19.
| Current Ratio | 2.40 |
| Quick Ratio | 2.37 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | 1.12 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -36.15% and return on invested capital (ROIC) is -20.65%.
| Return on Equity (ROE) | -36.15% |
| Return on Assets (ROA) | -13.66% |
| Return on Invested Capital (ROIC) | -20.65% |
| Return on Capital Employed (ROCE) | -28.78% |
| Revenue Per Employee | $564,343 |
| Profits Per Employee | -$542,537 |
| Employee Count | 134 |
| Asset Turnover | 0.20 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, GLUE has paid $2.57 million in taxes.
| Income Tax | 2.57M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.13% in the last 52 weeks. The beta is 1.53, so GLUE's price volatility has been higher than the market average.
| Beta (5Y) | 1.53 |
| 52-Week Price Change | -7.13% |
| 50-Day Moving Average | 5.45 |
| 200-Day Moving Average | 6.15 |
| Relative Strength Index (RSI) | 50.36 |
| Average Volume (20 Days) | 879,403 |
Short Selling Information
The latest short interest is 7.53 million, so 12.25% of the outstanding shares have been sold short.
| Short Interest | 7.53M |
| Short Previous Month | 5.41M |
| Short % of Shares Out | 12.25% |
| Short % of Float | 24.65% |
| Short Ratio (days to cover) | 7.16 |
Income Statement
In the last 12 months, GLUE had revenue of $75.62 million and -$72.70 million in losses. Loss per share was -$0.98.
| Revenue | 75.62M |
| Gross Profit | -37.24M |
| Operating Income | -81.11M |
| Pretax Income | -129.93M |
| Net Income | -72.70M |
| EBITDA | -72.99M |
| EBIT | -81.11M |
| Loss Per Share | -$0.98 |
Full Income StatementBalance Sheet
The company has $372.15 million in cash and $42.72 million in debt, giving a net cash position of $329.43 million or $5.36 per share.
| Cash & Cash Equivalents | 372.15M |
| Total Debt | 42.72M |
| Net Cash | 329.43M |
| Net Cash Per Share | $5.36 |
| Equity (Book Value) | 222.94M |
| Book Value Per Share | 3.62 |
| Working Capital | 220.49M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $42.00 million and capital expenditures -$3.99 million, giving a free cash flow of $38.01 million.
| Operating Cash Flow | 42.00M |
| Capital Expenditures | -3.99M |
| Free Cash Flow | 38.01M |
| FCF Per Share | $0.62 |
Full Cash Flow StatementMargins
Gross margin is -49.25%, with operating and profit margins of -107.26% and -96.14%.
| Gross Margin | -49.25% |
| Operating Margin | -107.26% |
| Pretax Margin | -92.74% |
| Profit Margin | -96.14% |
| EBITDA Margin | -96.52% |
| EBIT Margin | -107.26% |
| FCF Margin | 50.26% |
Dividends & Yields
GLUE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -43.80% |
| Shareholder Yield | -43.80% |
| Earnings Yield | -23.88% |
| FCF Yield | 12.48% |
Analyst Forecast
The average price target for GLUE is $14.33, which is 189.50% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.33 |
| Price Target Difference | 189.50% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 1.09% |
| EPS Growth Forecast (5Y) | 12.89% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
GLUE has an Altman Z-Score of -0.3 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.3 |
| Piotroski F-Score | 2 |